Who makes IV [14C] PF-06821497?

IV [14C] PF-06821497 is developed by Pfizer Inc..

What development phase is IV [14C] PF-06821497 in?

IV [14C] PF-06821497 is in Phase 1.

What is the generic name of IV [14C] PF-06821497?

iv-14c-pf-06821497 is the generic (nonproprietary) name of IV [14C] PF-06821497.

Last reviewed 2026-04-20 · How we verify

IV [14C] PF-06821497 (iv-14c-pf-06821497)

Pfizer Inc. · Phase 1 active Quality 0/100

At a glance

Generic name	iv-14c-pf-06821497
Sponsor	Pfizer Inc.
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

IV [14C] PF-06821497 CI brief — competitive landscape report
IV [14C] PF-06821497 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI